a public good project by the
Synthesis
Company
of California

© 2026

Daniel L. Cheney | doi.page

0 works0 citations0 h-index

Daniel L. Cheney

Bristol-Myers Squibb (Germany)(DE)Boise Cascade (Canada)(CA)

Publications by Year

Research Areas

Computational Drug Discovery Methods, Blood Coagulation and Thrombosis Mechanisms, Protein Structure and Dynamics, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Machine Learning in Materials Science

Most-Cited Works

→ New 4-Point Pharmacophore Method for Molecular Similarity and Diversity Applications: Overview of the Method and Applications, Including a Novel Approach to the Design of Combinatorial Libraries Containing Privileged Substructures(1999)376 cited
→ Macrocycle Conformational Sampling with MacroModel(2014)188 cited
→ Factor Xa Inhibitors: Next-Generation Antithrombotic Agents(2010)131 cited
→ Improving Accuracy, Diversity, and Speed with Prime Macrocycle Conformational Sampling(2017)112 cited
→ AP-Net: An atomic-pairwise neural network for smooth and transferable interaction potentials(2020)72 cited
→ In vitro characterization of benzodiazepine receptor agonists, antagonists, inverse agonists and agonist/antagonists.(1984)69 cited

→ Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: Discovery of novel, highly potent inhibitors of Factor Xa(2008)

55 cited

→ Atropisomer Control in Macrocyclic Factor VIIa Inhibitors(2016)53 cited

→ Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity(2002)52 cited

→ Discovery and Development of 5-[(5S,9R)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1(2006)51 cited